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We show that TR4 facilitates lipid accumulation in 3T3-L1 adipocytes via induction of the FATP1
gene. Further study showed that TR4 transactivated FATP1 50 promoter activity via direct binding
to the TR4 responsive element located at the FATP1 50 promoter region. Constitutive overexpression
of TR4 in 3T3-L1 adipocytes resulted in increased lipid accumulation, accompanied by an increase in
fatty acid uptake. However, small interfering RNA knockdown of FATP1 abolished TR4-enhanced
fatty acid uptake. Moreover, microRNA-mediated silencing of TR4 in 3T3-L1 adipocytes drastically
reduced basal FATP1 50 promoter activity and FATP1 expression with reduced lipid accumulation.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction in liver and white adipose tissue with decreased expression of he-Adipocytes are the principal cells for lipid storage and mobiliza-
tion in response to nutritional demands. Energy intake increases
plasma insulin level, which promotes fatty acid (FA) uptake into
adipocytes and intracellular lipid accumulation by esteriﬁcation of
fatty acids with glycerol [1]. Unesteriﬁed long-chain fatty acids
(LCFAs) are transported into mammalian cells predominantly via a
protein-mediated mechanism. Several membrane proteins, includ-
ing the fatty acid transport protein (FATP) family, FA translocase/
CD36, and plasma membrane FA-binding protein have been re-
ported to promote cellular uptake of LCFAs [2]. FATP1 belongs to
the FATP family; itwas the ﬁrst of this protein family to be identiﬁed
and is the best characterized in adipocytes [3]. It has been reported
that insulin promotes FATP1 translocation from an intracellular
compartment to theplasmamembraneandconcomitantly increases
LCFA uptake [1]. Consistently, gain-of-function studies have shown
that FATP1 increases FA import into adipocytes [4]. Moreover, loss
of FATP1 in mice decreases FA uptake in adipose tissue and skeletal
muscle with reduced fat mass, and elevates plasma FA level [3,5].
TR4, a member of the nuclear receptor superfamily, is able to
regulate the target gene expression through binding to different
AGGTCA direct repeats (DRs) [6]. Interestingly, recent studies
showed that TR4-deﬁcient mice showed reduced lipid depositionchemical Societies. Published by Epatic stearoyl-CoA desaturase1 or CD36 [7,8]. TR4 is expressed in
several tissues including adipose tissue, liver, and skeletal muscle,
which are important for lipid homeostasis, implying that TR4 may
also play a key role in lipid homeostasis of adipocytes [9].
Since the molecular mechanisms of adipogenesis have been
extensively studied and well characterized in 3T3-L1 cells, we
established 3T3-L1 cells constitutively overexpressing or silencing
TR4 to determine the TR4 role in lipid accumulation in adipocytes.
We demonstrated that TR4 facilitates lipid accumulation in 3T3-L1
adipocytes via increase of FATP1 expression and LCFA uptake.2. Materials and methods
2.1. Plasmids and reporter gene assay
See Supplementary data.
2.2. Cell culture, stable transfection, and differentiation
See Supplementary data.
2.3. Gel shift assay, chromatin immunoprecipitation (ChIP) assay and
Western blotting
See Supplementary data.lsevier B.V. All rights reserved.
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See Supplementary data.
2.5. Knockdown of FATP1 and fatty acid uptake assay
See Supplementary data.
3. Results
3.1. TR4 induces FATP1 expression in 3T3-L1 adipocytes
To study theeffect of TR4onexpressionof FA transporter genes in
adipocytes, we generated 3T3-L1 preadipocytes constitutively
expressing TR4 (3T3-L1-TR4). We induced differentiation of 2-day
post-conﬂuent3T3-L1preadipocytes (designatedday0) by standard
protocol andusedday6adipocytes toexamine theeffectofTR4over-
expression on expression of various FA transporter genes. By using
RT-qPCR and western blotting analyses, we found that TR4 overex-
pression signiﬁcantly induced FATP1 mRNA and protein expression
withmild induction of CD36 gene (Fig. 1A andB). Inductionof FATP1
gene by TR4 overexpression was further conﬁrmed in three other
independent stable cells overexpressing TR4 (Supplementary
Fig. 1A). Levels of ACSL1 and FATP1 mRNAs and proteins were also
slightly increased in 3T3-L1-TR4 adipocytes (Fig. 1A and B). In con-
trast, mRNA and protein levels of the adipogenic marker gene aP2
wasnot signiﬁcantly changedbyTR4overexpression. Indifferentiat-
ing day 2 MEF cells transiently transfected with TR4, FATP1 expres-
sion was also induced in parallel with an increase of TR4 (Fig. 1C).
Next, we assessed the impact of TR4 overexpression on the levels
of FATP1 mRNA at different stages of adipocyte differentiation.
FATP1 mRNA levels in 3T3-L1-TR4 cells were low during the ﬁrstFig. 1. TR4 increases FATP1 expression in 3T3-L1 adipocytes. (A, B) The mRNA and pro
western blotting in TR4 overexpressing (3T3-L1-TR4) or control adipocytes (3T3-L1-C) a
FATP1 mRNA expression in day 2 MEF cells transiently transfected with TR4 expression p
FATP1 mRNA expression in differentiating 3T3-L1 adipocytes was analyzed by RT-qPCRtwodaysofdifferentiation, butwere still higher than thoseof control
cells (3T3-L1-C) (Fig. 1D). After four days differentiation, FATP1
mRNA levels were drastically increased in both 3T3-L1-TR4 and
3T3-L1-C cells. However, elevated levels of FATP1 mRNA were ob-
served in 3T3-L1-TR4 cells throughout the course of differentiation.
3.2. TR4 induces FATP1 50 promoter activity via binding to the DR1 site
located at the FATP1 50 promoter
We next investigated whether TR4 could transcriptionally regu-
late FATP1 gene expression using a luciferase reporter linked to the
FATP1 50 promoter spanning 554 to +84 bp (pGL3-FATP1-554)
through transient transfection of NIH-3T3 cells. TR4 induced the
FATP1 50 promoter activity in a dose-dependent manner (Fig. 2A).
In contrast, the TR4 induction effect on FATP1 50 promoter activity
was not observed when pGL3-FATP1-440 or pGL3-FATP1-330 was
used (Fig. 2B). Sequence analysis of the FATP1 50 promoter region
between 554 and 440 bp revealed that one DR1 sequence
(GGGGCAAAGGGCA) was located at 470 to 458 bp. To deter-
mine TR4 binding to this putative TR4RE (FATP1-TR4RE), we per-
formed a gel shift assay. In vitro translated TR4 protein, but not
the mock-translated control lysate, formed a speciﬁc complex with
32P-labeled FATP1-TR4RE (Fig. 2C; lanes 1, 2, 6 and 7). This TR4/
FATP1-TR4RE complex was abolished when an excess amount of
FATP1-TR4RE, but not mutant FATP1-TR4RE, was added as compet-
itor (Fig. 2C; lanes 3 and 4). Furthermore, addition of anti-TR4 anti-
body resulted in the supershift of TR4/FATP1-TR4RE complex
(Fig. 2C; lane 5). In contrast, normal IgG or anti-RXRa antibody
did not supershift TR4/FATP1-TR4RE complex (Fig. 2C; lanes 8
and 9). To further conﬁrm TR4 binding to endogenous FATP1 50
promoter, we performed ChIP assays in NIH-3T3 cells transiently
transfected with TR4 expression plasmid. We found speciﬁc TR4tein levels of FATP1, CD36, FATP4, ACSL1, and aP2 were analyzed by RT-qPCR and
fter six days induction of differentiation (⁄P < 0.05, ⁄⁄P < 0.01, and ⁄⁄⁄P < 0.001). (C)
lasmid or control plasmid was analyzed by RT-qPCR (⁄P < 0.05 and ⁄⁄⁄P < 0.001). (D)
(⁄P < 0.05 and ⁄⁄⁄P < 0.001 vs. 3T3-L1-C).
Fig. 2. TR4 promotes FATP1 50 promoter activity via TR4RE. (A, B) Mouse FATP1 50 promoter-fused reporter gene construct (pGL3-FATP1-554, 300 ng) and its deletion
constructs (pGL3-FATP1-440 and pGL3-FATP1-330, 300 ng each) were co-transfected with TR4 expression plasmid into NIH-3T3 cells as indicated and luciferase activity was
analyzed (⁄P < 0.05 and ⁄⁄⁄P < 0.001). (C) Gel shift assay using 32P-labeled FATP1-TR4RE. Mock lysate or in vitro-translated TR4 was incubated with 32P-labeled FATP1-TR4RE.
Fifty molar excess of unlabeled wild type (wt) or mutated (mt) oligonucleotides were added as competitors and antibodies were added for supershift assay as indicated. (D)
Results of the ChIP assay. The cross-linked protein/DNA complex isolated from NIH-3T3 cells transfected with TR4 expression plasmid was immunoprecipitated with anti-TR4
antibody or normal IgG as indicated. The region (554 to 341 bp) containing the putative TR4 binding site of the FATP1 50 promoter was ampliﬁed from DNA extractions by
PCR. Lane 1 contains the input control. (E) Reporter gene construct (250 ng) fused with FATP1 50 promoter either containing (pGL3-FATP1-480) or lacking TR4RE (pGL3-
FATP1-457) was co-transfected without or with TR4 expression plasmid (150 ng) into NIH-3T3 cells and luciferase activity was analyzed (⁄P < 0.05 and ⁄⁄⁄P < 0.001 vs.
control).
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when we performed PCR to amplify the 554 to 341 bp region
from protein–DNA complexes immunoprecipitated by anti-TR4
antibody, but not by normal IgG control (Fig. 2D). Next, we
analyzed the importance of FATP1-TR4RE on TR4 transactivation
of the FATP1 50 promoter using two different reporter plasmids
fused to FATP1 50 promoter either containing (pGL3-FATP1-480)
or lacking FATP1-TR4RE (pGL3-FATP1-457). When TR4 was co-
transfected with pGL3-FATP1-480 into NIH-3T3 cells, TR4 induced
the reporter gene activity (Fig. 2E). In contrast, this TR4 induction
was dramatically decreased when pGL3-FATP1-480 was replaced
by pGL3-FATP1-457. Together, these data strongly suggest that
TR4 induces FATP1 gene expression via binding to FATP1-TR4RE
located in the FATP1 50 promoter.
3.3. TR4 overexpression increases lipid accumulation in 3T3-L1
adipocytes by enhancing LCFA uptake
Since the function of FATP1 in FA uptake and lipid accumulation
in adipocytes is well established, we analyzed the TR4 effect on li-
pid accumulation in 3T3-L1 adipocytes by using Oil Red O staining.
TR4 overexpression increased lipid accumulation in 3T3-L1 adipo-
cytes about 2.8-fold on day 5 and 2-fold on day 9 relative to that of
control adipocytes (Fig. 3A) and this TR4-induced lipid accumula-
tion in 3T3-L1 adipocytes was further conﬁrmed in other TR4 over-
expressing cells (Supplementary Fig. 1B). Consistently, 3T3-L1-TR4adipocytes showed about a 2-fold increase of 14C-labeled oleic acid
uptake relative to control 3T3-L1-C adipocytes under insulin-
stimulated conditions (Fig. 3B). Knockdown of FATP1 by FATP1-
speciﬁc siRNAs reduced LCFA uptake in both control and
3T3-L1-TR4 adipocytes. Moreover, this silencing of FATP1 abol-
ished TR4-enhanced LCFA uptake in 3T3-L1-TR4 adipocytes.
Knockdown of FATP1 signiﬁcantly decreased mRNA levels of
FATP1, but not of CD36, ACSL1, and FATP4 in 3T3-L1-TR4 adipo-
cytes, suggesting that TR4 facilitates LCFA inﬂux into 3T3-L1 adipo-
cytes via modulation of FATP1 expression (Fig. 3C). In addition,
when day 6 adipocytes were treated with 100 lM oleic acid for
48 h, oleic acid-induced cellular lipid accumulation in 3T3-L1-
TR4 adipocytes was more obvious than that of 3T3-L1-C adipocytes
(Fig. 3D).
3.4. Silencing of TR4 inhibits FATP1 expression and lipid accumulation
in 3T3-L1 adipocytes
To further determine the effect of TR4 on FATP1 expression and
lipid accumulation in 3T3-L1 adipocytes, we generated 3T3-L1
preadipocytes stably expressing scrambled (3T3-L1-miR) or three
different TR4 microRNAs (3T3-L1-TR4miR1, 3T3-L1-TR4miR2 and
3T3-L1TR4miR3) (Fig. 4A and Supplementary Fig. 2A). TR4 knock-
down by TR4miR3 signiﬁcantly inhibited mRNA expression of
FATP1 gene in day 8 3T3-L1 adipocytes by 60% compared with
3T3-L1-miR adipocytes. However, TR4 and FATP1 expression was
Fig. 3. TR4 promotes lipid accumulation in 3T3-L1 adipocytes via increase of FA uptake. (A) 3T3-L1 preadipocytes (3T3-L1-TR4 and 3T3-L1-C) were differentiated and stained
with Oil Red O to determine lipid accumulation on the days indicated (⁄⁄⁄P < 0.001 vs. 3T3-L1-C). (B) After 72 h transfection of FATP1 siRNAs or scrambled siRNA to day 5
adipocytes (3T3-L1-TR4 or 3T3-L1-C), cells were serum-starved for 1 h and then incubated with 6.2 nmol of 14C-labeled oleic acid for 20 min in HBSS buffer containing 5 lg of
insulin (⁄P < 0.05 and ⁄⁄P < 0.01). (C) Knockdown effect of FATP1 on the expression of CD36, FATP4, and ACSL1 genes was assessed by RT-qPCR (⁄P < 0.05 and ⁄⁄P < 0.01). (D)
After six days induction of differentiation, cells were treated with 100 lM oleic acid for 48 h and then stained with Oil Red O to determine oleic acid incorporation into cellular
lipids (⁄⁄⁄P < 0.001 vs. 3T3-L1-TR4 cells treated with BSA).
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adipocytes. CD36 mRNA expression was also reduced in 3T3-L1-
TR4miR3 adipocytes although reduction of CD36 mRNA was less
signiﬁcant than that of FATP1 gene. In addition, mRNA levels of
aP2 and FATP4 in 3T3-L1-TR4miR3 adipocytes were also mildly
reduced compared with 3T3-L1-miR adipocytes. In contrast, ACSL1
mRNA expression was not changed by TR4 knockdown. Western
blotting analysis showed that silencing of TR4 resulted in decrease
of FATP1 and CD36 protein expression without a signiﬁcant change
in FATP4, ACSL1 and aP2 protein expression (Fig. 4B). Furthermore,
silencing of endogenous TR4 in NIH-3T3 cells by transfection of
TR4miR3 inhibited basal transcriptional activity of the pGL3-
FATP1-554 in a dose-dependent manner (Fig. 4C). Consistently,
Oil Red O staining assay revealed that knockdown of TR4 by
TR4miR3 resulted in decrease of lipid accumulation in 3T3-L1
adipocytes by 50% relative to the control adipocytes (Fig. 4D and
Supplementary Fig. 2C). However, lipid accumulation in 3T3-L1-
TR4miR1 and 3T3-L1-TR4miR2 adipocytes was less signiﬁcant than
that of 3T3-L1-TR4miR3 adipocytes.
4. Discussion
Loss of TR4 leads to reduced lipid accumulation in liver and
adipose tissues [7,8]. Although TR4 may play important roles in
energy homeostasis, the role of TR4 in adipocyte biology remains
unknown. In the present study, we demonstrated a key role of
TR4 in lipid accumulation in 3T3-L1 adipocytes through the regu-
lation of FATP1 expression and FA uptake. We further showed that
TR4 induced FATP1 50 promoter activity via direct binding to the
TR4RE located in the FATP1 50 promoter. FATP1 and CD36 promoteLCFA uptake into differentiating adipocytes [2,10]. Interestingly,
the expression of CD36 can be regulated by TR4 in macrophages
and liver cells [8,11]. Accordingly, levels of CD36 mRNA and pro-
tein in 3T3-L1 adipocytes were increased by TR4. In addition,
ACSL1 and FATP4 also could be induced in 3T3-L1 adipocytes by
TR4. Thus, it is possible that CD36, ACSL1, and FATP4 genes also
play a role in TR4-induced lipid accumulation in adipocytes. How-
ever, in our study, addition of FATP1 siRNAs into TR4 overexpress-
ing 3T3-L1 adipocytes reduced only FATP1 mRNA level without
change in mRNA levels of CD36, ACSL1, and FATP4 and abolished
the promoting effect of TR4 on 14C-labeled oleic acid uptake. This
strongly suggests that TR4 may facilitate FA uptake into 3T3-L1
adipocytes predominantly via regulation of FATP1, although partial
contribution of other genes associated with FA transport in this
process could not be ruled out. Furthermore, the TR4 effect on
FATP1 expression and lipid accumulation in 3T3-L1 adipocytes
were further conﬁrmed by TR4 knockdown, which caused a de-
crease of FATP1 expression and lipid accumulation. FATP1 tran-
scription is regulated by nutrients and adipogenic regulators.
FATP1 mRNA expression is positively regulated by PPARc which
plays an important role in adipogenesis [12]. Interestingly, the adi-
pogenic hormone insulin negatively regulates FATP1 mRNA
expression but does not affect FATP1 protein level in adipocytes
[1]. Insulin increases LCFA uptake via promoting FATP1 transloca-
tion from an intracellular compartment to the plasma membrane
[1]. Thus, this strongly suggests that TR4 and other adipogenic
key regulators might orchestrate to ﬁne-tune FATP1 expression
under various metabolic cues. Taken together, our study demon-
strates that TR4 plays an important role in lipid accumulation in
adipocytes via regulation of FATP1 expression.
Fig. 4. Silencing of TR4 inhibits FATP1 expression and lipid accumulation in 3T3-L1 adipocytes. (A, B) The mRNA and protein levels of FATP1, CD36, FATP4, ACSL1, and aP2
were analyzed by RT-qPCR and western blotting in TR4 knockdown (3T3-L1-TR4miR3) or control adipocytes (3T3-L1-miR) after six days induction of differentiation (⁄P < 0.05,
⁄⁄P < 0.01, and ⁄⁄⁄P < 0.001 vs. 3T3-L1-miR). (C) Increasing amounts of TR4miR3 expression plasmid were co-transfected with pGL3-FATP1-554 into NIH-3T3 cells and
luciferase activity was analyzed (⁄P < 0.05 and ⁄⁄⁄P < 0.001). (D) Reduction in lipid accumulation of 3T3-L1 adipocytes by TR4 knockdown. Cells were differentiated for seven
days and then lipid accumulation was determined by Oil Red O staining (⁄⁄⁄P < 0.001).
H. Choi et al. / FEBS Letters 585 (2011) 2763–2767 2767Acknowledgements
This work was supported by National Research Foundation of
Korea Grant funded by the Korean Government (KRF-2006-312-
C00392).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.08.002.
References
[1] Stahl, A., Evans, J.G., Pattel, S., Hirsch, D. and Lodish, H.F. (2002) Insulin causes
fatty acid transport protein translocation and enhanced fatty acid uptake in
adipocytes. Dev. Cell 2, 477–488.
[2] Pohl, J., Ring, A., Hermann, T. and Stremmel, W. (2004) Role of FATP in
parenchymal cell fatty acid uptake. Biochim. Biophys. Acta 1686, 1–6.
[3] Wu, Q., Ortegon, A.M., Tsang, B., Doege, H., Feingold, K.R. and Stahl, A. (2006)
FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced
obesity. Mol. Cell Biol. 26, 3455–3467.[4] Schaffer, J.E. and Lodish, H.F. (1994) Expression cloning and characterization of
a novel adipocyte long chain fatty acid transport protein. Cell 79, 427–436.
[5] Kim, J.K. et al. (2004) Inactivation of fatty acid transport protein 1 prevents fat-
induced insulin resistance in skeletal muscle. J. Clin. Invest. 113, 756–763.
[6] Kim, E. et al. (2003) Disruption of TR4 orphan nuclear receptor reduces the
expression of liver apolipoprotein E/C-I/C-II gene cluster. J. Biol. Chem. 278,
46919–46926.
[7] Kim, E., Liu, N.C., Yu, I.C., Lin, H.Y., Lee, Y.F., Sparks, J.D., Chen, L.M. and Chang,
C. (2011) Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-
CoA desaturase 1 gene expression with altered insulin sensitivity. Diabetes 60,
1493–1503.
[8] Kang, H.S. et al. (2011) Nuclear orphan receptor TAK1/TR4-deﬁcient mice are
protected against obesity-linked inﬂammation, hepatic steatosis, and insulin
resistance. Diabetes 60, 177–188.
[9] Bookout, A.L., Jeong, Y., Downes, M., Yu, R.T., Evans, R.M. and Mangelsdorf, D.J.
(2006) Anatomical proﬁling of nuclear receptor expression reveals a
hierarchical transcriptional network. Cell 126, 789–799.
[10] Kontrova, K. et al. (2007) CD36 regulates fatty acid composition and sensitivity
to insulin in 3T3–L1 adipocytes. Physiol. Res. 56, 493–496.
[11] Xie, S. et al. (2009) TR4 nuclear receptor functions as a fatty acid sensor to
modulate CD36 expression and foam cell formation. Proc. Natl. Acad. Sci. USA
106, 13353–13358.
[12] Frohnert, B.I., Hui, T.Y. and Bernlohr, D.A. (1999) Identiﬁcation of a functional
peroxisome proliferator-responsive element in the murine fatty acid transport
protein gene. J. Biol. Chem. 274, 3970–3977.
